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Abstract: In the post-polio eradication era, increasing attention is given to non-polio enteroviruses.
Most of the data about enteroviruses in sub-Saharan Africa are related to acute flaccid paralysis
surveillance and target the pediatric population. This study aimed to investigate the presence
of enterovirus in PLHIV (people living with HIV) and HIV-negative individuals in Ghana. Stool
samples from HIV-positive individuals (n = 250) and healthy blood donors (n = 102) attending the
Komfo Anokye Teaching Hospital in Kumasi, Ghana, were screened by real-time PCR for enterovirus.
Molecular typing of the VP1 region was performed. Enterovirus-positive samples were tested for
norovirus, adenovirus, rotavirus, sapovirus, and cosaviruses. Twenty-six out of 250 HIV-positive
subjects (10.4%) and 14 out of 102 HIV-negative individuals (13.7%) were detected enterovirus-positive,
not showing a significant different infection rate between the two groups. HIV-negative individuals
were infected with Enterovirus C strains only. HIV-positive participants were detected positive
for species Enterovirus A, Enterovirus B, and Enterovirus C. Co-infections with other viral enteric
pathogens were almost exclusively detected among HIV-positive participants. Overall, the present
study provides the first data about enteroviruses within HIV-positive and HIV-negative adults living
in Ghana.
Keywords: enterovirus; HIV; Ghana; cosavirus; enteric infection
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1. Introduction
Enteroviruses belong to the family Picornaviridae and are non-enveloped single stranded RNA
viruses. So far more than 100 different serotypes have been identified to infect humans and grouped
into 4 species (Enterovirus A- Enterovirus D) on the basis of their genetic divergence [1]. Enteroviruses
are endemic worldwide and mainly transmitted via the fecal–oral route or by droplets and direct
contacts [2]. The most known members of the genus Enterovirus are represented by the three poliovirus
types (PV), assigned within the species Enterovirus C. Polioviruses are the etiologic agents of paralytic
poliomyelitis, an infectious disease characterized by acute flaccid paralysis (AFP) and whose main
target is children under 5 years of age [3]. The success of the Global Polio Eradication Initiative (GPEI)
has dramatically reduced the circulation of wild PVs [4]. Since 1988, the number of polio endemic
countries has declined from 125 to 3, represented by Nigeria, Pakistan and Afghanistan, with Nigeria
being on the verge of being certified as polio free [4,5].
In the post-polio eradication era, increasing attention is given worldwide to the detection
and characterization of non-polio enteroviruses [6,7]. Although enterovirus infections are mostly
asymptomatic, the available data evidenced a high pathogenic potential. Different non-polio
enteroviruses have been isolated from patients affected from AFP in the context of polio surveillance [6].
Other severe clinical forms associated with enteroviruses include aseptic meningitis, myocarditis,
encephalitis, and respiratory diseases [8,9]. Age, gender, and host immune status can influence the
clinical presentation and severity of infection [10]. Furthermore, emerging enterovirus variants have
been recognized worldwide as causes of severe clinical manifestations in both sporadic and epidemic
cases [11–18].
In Europe, the non-polio enterovirus network (ENPEN) was recently established, with the aim to
collect data on severe enterovirus infections and monitor the circulation of enterovirus types [19].
In sub-Saharan Africa, the limited data about enterovirus infections are mostly related to AFP
surveillance [20–22]. A previous survey in Côte d’Ivoire evidenced a high variety of enterovirus strains
circulating in apparently healthy individuals [23]. A high diversity in enterovirus isolates infecting
healthy individuals was also observed in other African countries [24,25].
Malnutrition and inadequate supply of water, sanitation, and hygiene presumably play a crucial
role in the spread of this group of viruses [26]. However, few data are available about the presence
of enteroviruses in immunocompromised individuals living in these areas, namely PLHIV (people
living with Human Immunodeficiency Virus). Chronic meningoencephalitis associated to enterovirus
in immunocompromised patients have long been known [27–29]. Nevertheless, the potential role of
HIV-positive patients as a source of enterovirus infections in tropical areas has been barely examined [30].
As known, the depletion of CD4+ T lymphocytes and the associated impairment of the immune
system make HIV patients more vulnerable to acquiring other infections and to developing more severe
clinical manifestations [31]. Remarkably, co-infections with enteric parasitic infections are reported to
worsen the progression of the HIV infection to Acquired Immunodeficiency Syndrome (AIDS) [32].
On the contrary, a potential beneficial immunomodulatory effect was evidenced in case of co-infection
with Helicobacter pylori in HIV-positive persons [33,34]. The impact of enteric viruses in HIV-positive
people living in low-income countries is poorly investigated; however, they are considered a relevant
cause of morbidity in this group of patients [35]. Furthermore, HIV progression was associated with
the expansion of enteric virome [36,37].
In Ghana, 300,000 people are estimated to be living with HIV/AIDS and only 70,000 of them are
reported to have access to antiretroviral therapy (ART) [38].
The aim of the present study was to analyze and molecularly characterize the spectrum of
enteroviruses infecting HIV-positive and HIV-negative adults living in Ghana, in order to evidence if
HIV infection was associated with a higher risk for infection with enteroviruses.
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2. Materials and Methods
2.1. Study Participants
The present study comprised participants from an observational cohort study on clinical
and sociodemographic determinants of H. pylori infection among HIV-infected and non-infected
persons [33,34]. Adult HIV-positive patients from the HIV Outpatient Department of the Komfo
Anokye Teaching Hospital in Kumasi, Ghana, were enrolled between November 2011 and November
2012. Additionally, blood donors from the same hospital were recruited to serve as a HIV-negative
control group. From this cohort, we randomly selected HIV-positive patients with CD4+ T cell counts
below or more than 200 cells/µL (n= 119 and 131, respectively), and 102 HIV-negative individuals to
analyze the prevalence and clinical implications of human enteroviruses.
2.2. Ethics Statement
Ethical approval for this study was obtained from the Committee on Human Research of the
Kwame Nkrumah University of Science and Technology in Kumasi, Ghana: HRPE/AP/12/11, and the
ethics committee of the Medical Council in Hamburg, Germany: PV3771. Written informed consent was
obtained from all participants before enrolment in accordance with the World Medical Association’s
Declaration of Helsinki.
2.3. Specimen Collection, Handling and Storage
Trained study personnel collected demographic and clinical data using a standardized
questionnaire. Aliquots of native stool samples were freshly frozen and stored at −80 ◦C before
being transported to Germany on dry ice. Blood samples were collected and the analysis of CD4+ T
cell count was performed in Ghana using a FACSCalibur flow cytometer (Becton Dickinson, Mountain
View, California).
2.4. Viral Nucleic Acid Extraction
A 10% suspension of each stool sample was prepared using PBS. Viral nucleic acids were extracted
from 700 µL of the stool suspension by using the automated platform VERSANT kPCR Molecular
System and the VERSANT Sample Preparation 1.0 Reagents Kit (Siemens Healthcare Diagnostics,
Erlangen, Germany) into an elution volume of 100 µl, according to the manufacturer’s instructions.
2.5. Detection of Enteroviruses and Other Viral Enteric Co-Infections
Samples were screened for enteroviruses using the Enterovirus real-time RT-PCR Kit (TaqMan)
(AnDiaTec GmbH & Co.KG, Kornwestheim, Germany) according to the manufacturer’s protocol.
Enterovirus-positive samples were screened for the presence of other viral enteric pathogens. Norovirus
(NoV), adenovirus (AdV), rotavirus (RV), astrovirus (HAstV), and sapovirus (SaV) were detected using
the multiplex FTD Viral gastroenteritis (Fast-Track Diagnostics, Luxembourg), in accordance with the
manufacturer’s instructions. Cosaviruses (CoSV) were detected as described by Kapoor et al. [39].
2.6. VP1 Amplification, Sequencing and Molecular Typing
All enterovirus strains were sequenced in the 5′ non-coding region (5′NCR) for enterovirus
species assignment. Molecular typing of enterovirus strains was performed using generic and
species-specific VP1-primer systems [23,25]. Sequencing was done directly on amplification products
using BigDye 3.1 (Applied Biosystems). Assignment to enterovirus types was done using BLAST
and the Enterovirus Genotyping Tool [40,41]. Sequences were deposited in GenBank under accession
numbers MN812172-MN812201.
In addition to molecular assays, enterovirus-positive stool samples were inoculated to RD-A
cells and passaged three times. If CPE was observed, RNA was extracted from 140 µL cell culture
Viruses 2020, 12, 221 4 of 13
supernatant and subjected to enterovirus PCR, targeting the 5′ non-coding region (NCR) and VP1
region. Sequencing was performed to exclude the presence of polioviruses.
2.7. Statistical Analysis
Statistical analyses were conducted using R (version 3.6.1, R Foundation for Statistical Computing,
Vienna, Austria). Categorical variables were compared using either the χ2 test or the Fisher exact test,
as appropriate. Continuous variables were expressed as median (interquartile range, IQR) or mean ±
standard deviation (SD) and compared using the Wilcoxon rank sum test or the unpaired Student’s
t-test. A multiple linear regression model was used to assess the association between covariates and
the continuous outcome CD4+ T cell count cells/µL. Two-sided p-values were presented, and statistical
significance was determined at α = 5%.
3. Results
3.1. Characteristics of Enterovirus-positive and Negative Participants
Forty (11.4%) out of 352 stool samples were tested positive for enteroviruses (Table 1).
Out of 250 samples of HIV-positive subjects, twenty-six (10.4%) were tested enterovirus-positive,
and fourteen out of 102 HIV-negative individuals (13.7%, p = 0.362) were tested enterovirus-positive
(Figure 1a). The proportion of HIV infections was not different between enterovirus-positive
and enterovirus-negative participants (65.0% vs. 71.8%, respectively). Furthermore, the two
groups did not differ regarding the presence of clinical symptoms between enterovirus-positive
and enterovirus-negative individuals. Remarkably, within the group of HIV-positive participants,
those with an enterovirus infection had significantly higher median CD4+ T cell counts compared to
those that were tested enterovirus-negative (416 [IQR 168-535] vs 204 [IQR 78-460] cells/µL, p = 0.017),
but did not differ in regard to antiretroviral therapy, intake of antibiotics, or time since diagnosis of
HIV (Table S1 and S2). Interestingly, this finding was restricted to HIV-positive subjects and was not
observed in participants without HIV infection. On the other hand, HIV-negative adults infected
with enterovirus were significantly younger than those without enterovirus infection (28.6 ± 6.4 vs.
33.6 ± 12.9, p = 0.029).
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Table 1. Demographical and clinical characteristics of enterovirus-positive and enterovirus-
negative participants.
Parameters Total (n = 352) Enterovirus-PositiveSubjects (n = 40, 11.4%)
Enterovirus-Negative
Subjects (n = 312, 88.6%) p-Value
Age in years, mean ± SD: 38.2 ± 10.6 37.7 ± 10.7 38.3 ± 10.6 0.760
in HIV-positive subjects 40.3 ± 9.1 42.3 ± 9.2 40.0 ± 9.1 0.186
in HIV-negative subjects 32.9 ± 12.3 28.6 ± 6.4 33.6 ± 12.9 0.029
Female gender, n (%) 247 (70.6) 31 (77.5) 216 (69.7) 0.307
HIV status:
positive, n (%) 250 (71.0) 26 (65.0) 224 (71.8)
0.372negative, n (%) 102 (29.0) 14 (35.0) 88 (28.2)
CD4+ T cells/µL (IQR):
in HIV-positive subjects 221 (87–474) 416 (168–535) 204 (78–460) 0.017
in HIV-negative subjects 969 (786–1150) 958 (769–1038) 982 (787–1153) 0.726
Low BMI (<18.5 kg/m2), n (%): 37 (11.1) 1 (2.7) 36 (12.2) 0.099
in HIV-positive subjects 34 (13.9) 1 (3.8) 33 (15.1) 0.143
in HIV-negative subjects 3 (3.4) 0 (0.0) 3 (3.9) 1.00
Clinical symptoms during last
6 months:
Gastrointestinal symptoms, n (%) 64 (18.4) 8 (20.0) 56 (18.2) 0.780
Feverish symptoms, n (%) 42 (18.5) 5 (18.5) 37 (18.5) 0.998
Cough, n (%) 56 (16.1) 7 (17.5) 49 (15.9) 0.797
Skin rashes, n (%) 26 (7.5) 3 (7.5) 23 (7.5) 1.000
Access to tap water, n (%) 190 (54.6) 21 (52.5) 169 (54.9) 0.777
Fridge/freezer in household, n (%) 249 (71.6) 30 (75.0) 219 (71.1) 0.607
Electricity in household, n (%) 326 (93.7) 40 (100.0) 286 (92.9) 0.091
IQR—interquartile range; SD—standard deviation; BMI—Body Mass Index.
3.2. Enterovirus Typing
Enterovirus strains were characterized by sequencing the V1 region for type assignment. For strains
remaining negative for VP1 amplification, sequencing of the 5′ 5′NCR allowed enterovirus species
assignment. Thirty-three strains could be assigned to a type and six could be typed on species level.
One real-time RT-PCR positive sample remained negative in the typing PCR assays. The identified
enterovirus types were assigned to species Enterovirus A, Enterovirus B and Enterovirus C (Table 2).
The presence of polioviruses was also excluded using cell culture assays. Only one stool sample (HP0932)
showed CPE in RD-A cells and molecular typing resulted in EV-A76 detection. Remarkably, whereas
HIV-negative individuals were infected exclusively with Enterovirus C strains, HIV-positive participants
also showed infections with Enterovirus A strains and Enterovirus B strains (Figure 1a,b). None of
the 15 HIV-infected participants with Enterovirus C strains detected reported any gastrointestinal
complaints and thirteen out of them had CD4+ T cell counts higher than 200 cells/µL (Table 2).
In contrast to this, four out of five participants with Enterovirus A strain co-infection had CD4+ T cell
counts below 200 cells/µL.
3.3. Co-Infection with Other Enteric Viruses
Fifteen (37.5%) out of 40 enterovirus-positive participants were co-infected with additional enteric
viruses. Out of them, 10 samples were tested positive for one further viral pathogen and 5 samples for
2 other viruses. AdV and CoSV were the most common co-infections (Table 2). Remarkably, all but one
of these infections with additional enteric pathogens were observed in HIV-positive individuals. It is
worth noting that four of five co-infections with CoSV in HIV-positive participants were detected in
subjects with CD4+ T cell counts below 200 cells/µL (p = 0.02).
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Table 2. Characteristics, clinical features and enterovirus typing results of enterovirus-positive adults living in Ghana.
ID HIVStatus Sex
Age in
Years
CD4+ T
Cells/µl On ART
Feverish
Symptoms Cough
Gastrointestinal
Symptoms
Skin
Rashes
Enterovirus
Typing Result
Enterovirus
Species
Other Enteric
Infections
CHP012 neg f 33 NA NA - - - - Enterovirus C Enterovirus C -
CHP013 neg f 23 1276 NA - - - - CVA19 Enterovirus C -
CHP021 neg f 32 921 NA - - - - CVA13 Enterovirus C -
CHP023 neg f 28 940 NA - - + - Enterovirus C Enterovirus C -
CHP027 neg m 23 977 NA - - - - CVA20 Enterovirus C -
CHP028 neg f 29 735 NA + + - - CVA13 Enterovirus C -
CHP029 neg f 26 1698 NA - - - - EV-C99 Enterovirus C -
CHP042 neg f 33 967 NA + - + + Enterovirus C Enterovirus C -
CHP051 neg m 19 958 NA - - + - CVA19 Enterovirus C -
CHP061 neg m 22 1381 NA - - - - EV-C99 Enterovirus C CoSV-D
CHP065 neg m 39 680 NA - - - - Enterovirus C Enterovirus C -
CHP105 neg f 25 1038 NA - - + + Enterovirus C Enterovirus C -
CHP138 neg m 27 363 NA - - - - CVA20 Enterovirus C -
CHP165 neg f 41 769 NA - + - - EV-C99 Enterovirus C -
HP0008 pos f 55 65 - NA - + - EV-A119 Enterovirus A AdV, CoSV-A
HP0010 pos m 56 522 + + - - - EV-C99 Enterovirus C NoV G2, AdV
HP0038 pos m 38 396 + NA - - - CVA5 Enterovirus A -
HP0063 pos f 40 470 + NA - - - EV-C99 Enterovirus C -
HP0120 pos f 50 331 - NA - - - CVA20 Enterovirus C -
HP0123 pos f 28 134 - NA - - - CVA17 Enterovirus C AdV
HP0130 pos f 30 465 - NA - - - Enterovirus C Enterovirus C -
HP0210 pos f 48 356 - + - - - E27 Enterovirus B NoV GI
HP0216 pos m 43 851 - NA - - - EV-C113 Enterovirus C -
HP0255 pos f 26 455 - NA - - - EV-C113 Enterovirus C -
HP0274 pos f 43 539 + NA + - - CVA20 Enterovirus C AdV
HP0297 pos f 36 655 + NA + + - EV-B74 Enterovirus B SaV
HP0335 pos f 36 391 + NA - - - EV-C113 Enterovirus C SaV
HP0361 pos f 27 725 + NA - - - CVA20 Enterovirus C -
HP0407 pos f 47 1677 + NA - - - CVA19 Enterovirus C -
HP0578 pos f 59 635 + - - - - CVA13 Enterovirus C NoV GII
HP0648 pos f 57 318 - - - - - E14 Enterovirus B -
HP0762 pos f 45 151 - - - - - EV-A119 Enterovirus A AdV, CoSV-D
HP0800 pos f 44 555 - + + + - EV-B106 Enterovirus B AdV
HP0845 pos m 39 93 - - - - - CVB6 Enterovirus B CoSV-D
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Table 2. Cont.
ID HIVStatus Sex
Age in
Years
CD4+ T
Cells/µl On ART
Feverish
Symptoms Cough
Gastrointestinal
Symptoms
Skin
Rashes
Enterovirus
Typing Result
Enterovirus
Species
Other Enteric
Infections
HP0916 pos f 38 181 + - - - - CVA20 Enterovirus C -
HP0932 pos f 51 83 - - + + + EV-A76 Enterovirus A CoSV-B
HP0995 pos f 37 435 + - + - - CVA13 Enterovirus C SaV, CoSV-D
HP1007 pos f 47 87 + - - - - EV-A119 Enterovirus A NoV GII2, AdV
HP1097 pos f 40 163 - - - - - Positive NA -
HP1107 pos f 48 466 - - - - - EV-C99 Enterovirus C -
+—present; —-not present; f—female; m—male.
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3.4. Factors Associated with CD4+ T Cell Count in HIV-Positive Participants With and Without Enterovirus
Co-Infection
In the simple linear regression models age, ART-intake and being infected with Enterovirus C
strains compared to not carrying enteroviruses were significantly associated with an increased CD4+ T
cell count in HIV-positive participants (Table 3). When adjusting for age, sex and ART-intake, detection
of Enterovirus C strains was still found to be independently associated with a higher CD4+ T cell count
in HIV-positive participants compared to those with an enterovirus-negative status (p = 0.042).
Table 3. Factors associated with increased CD4+ T cell count in HIV-positive participants with and
without enterovirus co-infection.
HIV-Positive With and Without Enterovirus Co-Infection
Simple Linear Regression
Models
Multiple Linear Regression
Model
Variable β-Coef p Value β-Coef p Value
Age in years 4.12 0.077 3.91 0.073
Male −41.74 0.381 −28.65 0.517
ART intake 275.13 <0.001 262.09 <0.001
Enterovirus species compared to
enterovirus-negative status
Enterovirus A −160.03 0.287 −199.38 0.152
Enterovirus B 78.975 0.599 101.43 0.465
Enterovirus C 235.37 0.008 167.77 0.042
ART—antiretroviral therapy; β-Coef—linear regression coefficient.
4. Discussion
Non-polio enteroviruses are recognized worldwide as an emerging cause of different diseases.
The outbreaks caused by enteroviruses that affected Europe, America and Asia in the recent years
evidenced the high pathogenic potential of this group of viruses [42].
Data on enterovirus infections circulating in people living in sub-Saharan Africa are still limited
and mostly addressing the pediatric population. Recently, Brouwer et al. detected enteroviruses by
real-time RT-PCR in 89.9% of fecal samples collected from a cohort of children ≤ 5 years of age in
Malawi, not showing differences in enterovirus detection rates between children with and without
severe anemia [43]. So far, no other studies could evidence a comparable high detection rate [44].
In our present cohort 40 out of 352 stool samples were tested positive for enteroviruses, indicating
a detection rate of 11.4%. Although apparently modest, this result confirms that enterovirus circulation
in Ghana is a phenomenon not limited to childhood, considering that the mean age of participants
was 38.2 (± 10.6). Nevertheless, we observed a lower mean age in HIV-negative participants infected
with enterovirus compared to those without enterovirus infection in our adult cohort. A recent study
reported a similar infection rate in healthy individuals living in Nigeria, including children and
adults [25]. Apparently, HIV infection was not shown to be associated with a higher rate of enterovirus
infections compared to HIV-negative adults. Previous available data seem to confirm this result
regardless of age [45,46].
However, the higher diversity of enteroviruses as well as the detection of rare and zoonotic
enterovirus types, mostly in HIV-positive individuals, provide further incentives to understand better
the meaning of enterovirus infections within PLHIV.
In our study, the majority of strains were assigned to Enterovirus C (29/39), which is often described
as the most common group circulating in sub-Saharan Africa [43,47]. Within this species, CVA20 and
EV-C99 were the most common serotypes identified in our cohort. Although both serotypes have
been isolated from AFP patients, they have been more commonly identified in apparently healthy
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individuals [23,25,43,48]. In our cohort, all but one of the HIV-positive individuals infected with these
serotypes had a CD4+ T cell count higher than 200 cells/µL. These two serotypes could be detected in
both HIV-positive and HIV-negative individuals. On the contrary, the rarely reported EV-C113 was
detected in HIV-positive patients only [49].
Interestingly, the detection of enterovirus strains belonging to the species Enterovirus A and
Enterovirus B was restricted to HIV-infected participants. In particular, two HIV-positive participants
with CD4+ T cell count > 200 cells/µL were detected positive for two rarely described serotypes, namely
EV-B106 and EV-B74 [50,51].
The serotype EV-A119 was detected in three female HIV-positive individuals with CD4+ T cell
counts below 200 cells/µL and an age of 45 years or higher, whereas EV-A76 was found in a HIV-positive
patient with a low CD4+ T cell count and multiple clinical complaints, including cough, gastrointestinal
symptoms, and skin rush. Both of them are known for their zoonotic potential and have been isolated
in non-human primates in West and Central Africa [52–55].
The observation that in our cohort only PLHIV were infected with rarely circulating serotypes
represents a novel evidence whose meaning needs to be investigated further. The impairment of
gastrointestinal immunity induced by HIV might be one possible explanation.
In line with this result, infections with other enteric viral pathogens in addition to infection with
enteroviruses could be found almost exclusively in HIV-positive patients.
It is interesting to note that the detection of CoSV infections in enterovirus-positive individuals
(6/40, 15%) was rather higher when compared to the limited available data of other cohorts of adults [25].
So far, CoSV infections in adults have been rarely reported worldwide. CoSV were found in one of
1000 adult patients with gastroenteritis in Scotland and in one of 150 stool samples from adults with
diarrhea living in Thailand [39,56]. Similar data were obtained from immunocompromised individuals.
Among HIV-infected patients, CoSV were detected in one of 154 patients suffering from gastroenteritis
in Brazil and in three of 196 patients with and without diarrhea in the Netherlands [57,58]. A case of
persistent CoSV infection and chronic diarrhea was also described in a lung transplant recipient [59].
In the present cohort, the almost exclusive detection of other viral enteric agents in
enterovirus-positive persons infected with HIV is suggestive of an altered intestinal mucosal immunity
affecting this group of patients.
A recent investigation targeting a cohort of Ugandan patients evidenced that advanced HIV/AIDS
is associated with the expansion of enteric virome, in particular adenoviruses [36]. Our data confirmed
a higher burden, in terms of enterovirus variability and rate of co-infections with other gastrointestinal
viruses, among HIV-infected patients compared to HIV-negative individuals. Adenovirus represented
the most common viral agent detected as co-infection.
The association of the CD4+ T cell count in HIV-positive individuals with different enterovirus
species represents a new aspect of the present study. Rarely reported Enterovirus A infections as well as
infections with zoonotic potential types were almost exclusively detected in HIV-positive individuals
with an impaired immune system, as indicated by a low CD4+ T cell count.
Contrastingly, the infection with members of Enterovirus C types in HIV-positive participants
was independently associated with a higher CD4+ T cell count compared to PLHIV not infected with
enteroviruses. So far, Enterovirus C is the only species of human enteroviruses that was not detected in
animals, confirming it as highly specific to humans. Considering that Enterovirus C species is more
prevalent in healthy people, it might be supposed that members of this group of viruses are able to
stably replicate in the human gut, reflecting a favorable health status [60]. On the other hand, the higher
CD4+ T cells/µL count detected in HIV+ individuals infected with Enterovirus C strains compared
to HIV-positive participants without enterovirus infection might indicate a cell-mediated immune
response toward the co-infection.
Another remarkable aspect of this study is represented by the fact that co-infection with CoSV was
significantly more common in enterovirus-infected PLHIV with CD4+ T cell counts below 200 cells/µL,
indicating the potential role of CoSV as an opportunistic agent.
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Overall, the present study provides the first data about enteroviruses and additional enteric
co-infections within HIV-positive and HIV-negative adults living in Ghana. Although infections with
enteroviruses were not more frequent in PLHIV, a higher diversity of enteroviruses, including rare and
zoonotic types, was predominantly detected among HIV-positive individuals with a low CD4+T cell
count. Infections with additional enteric viruses were almost exclusively detected among HIV-infected
individuals, confirming the detrimental effect of HIV on gut homeostasis. As prolonged enterovirus
shedding might be a biomarker for defective immune defenses against enteroviruses, it would be of
interest if HIV-positive individuals infected with enterovirus had prolonged shedding of the same
serotype in consecutive stool samples. Therefore, further longitudinal studies are required to gain
more comprehensive knowledge about the role of such viruses on gut homeostasis.
Surveillance of non-polio enterovirus diversity among distinct patient groups in African countries,
including PLHIV, plays an important role in not underestimating this neglected occurrence of EV
infections and their potential impact on public health.
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